There exist only two case reports to date of open cardiac defibrillation with deep brain stimulator system (DBS) implantation. We report a 64-year-old male with DBS system in place for essential tremor who underwent cardiac defibrillation after cardiac arrest. Afterwards, his device impedances were all high and his tremor symptoms returned. Both problems resolved with implantation of a new generator and required no changes to the intracranial leads or extension cables. This is significantly different from the two previous reports. One included a significantly different DBS system relying on transcutaneous RF transmission and reported a lesioning effect after cardioversion. The other utilized a modern DBS system but reported damage to the generator and intracranial leads. We report that only the generator sustained damage, and that there were no intracranial changes that occurred.

1.
Ben-Shlomo
Y
,
Marmot
MG
.
Survival and cause of death in a cohort of patients with parkinsonism: possible clues to aetiology?
J Neurol Neurosurg Psychiatry
.
1995
Mar
;
58
(
3
):
293
9
.
[PubMed]
0022-3050
2.
Elliott
M
,
Momin
S
,
Fiddes
B
,
Farooqi
F
,
Sohaib
SA
.
Pacemaker and defibrillator implantation and programming in patients with deep brain stimulation
.
Arrhythm Electrophysiol Rev
.
2019
May
;
8
(
2
):
138
42
.
[PubMed]
2050-3369
3.
Yamamoto
T
,
Katayama
Y
,
Fukaya
C
,
Kurihara
J
,
Oshima
H
,
Kasai
M
.
Thalamotomy caused by cardioversion in a patient treated with deep brain stimulation
.
Stereotact Funct Neurosurg
.
2000
;
74
(
2
):
73
82
.
[PubMed]
1011-6125
4.
Sobstyl
M
,
Michałowska
M
,
Fiszer
U
,
Ząbek
M
.
Deep brain stimulation failure due to external cardioversion in a patient with Parkinson’s disease
.
Neurol Neurochir Pol
.
2017
Jul - Aug
;
51
(
4
):
324
30
.
[PubMed]
0028-3843
5.
Elias
WJ
,
Huss
D
,
Voss
T
,
Loomba
J
,
Khaled
M
,
Zadicario
E
, et al.
A pilot study of focused ultrasound thalamotomy for essential tremor
.
N Engl J Med
.
2013
Aug
;
369
(
7
):
640
8
.
[PubMed]
0028-4793
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.